Search research articles
Contact Us
Filters
Showing results (41-50 of 103) with videos related to
Page
of 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2014
Trastuzumab emtansine in human epidermal growth factor receptor 2-positive metastatic breast cancer: an integrated safety analysis
Véronique Diéras, Nadia Harbeck, G Thomas Budd, et al.
Breast Cancer Research and Treatment
|
April 28, 2004
A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer
Gary H Lyman, Stephanie J Green, Peter M Ravdin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 8, 2012
Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy
Rahul D Tendulkar, Sana Rehman, Monica E Shukla, et al.
Cancer
|
February 14, 2017
Impact of an alternative chromosome 17 probe and the 2013 American Society of Clinical Oncology and College of American Pathologists guidelines on fluorescence in situ hybridization for the determination of HER2 gene amplification in breast cancer
Alana R Donaldson, Shashirekha Shetty, Zhen Wang, et al.
Clinical Breast Cancer
|
November 6, 2021
Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors
Hanjie Mo, Catherine E Renna, Halle C F Moore, et al.
Human Pathology
|
May 14, 2005
The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study
David G Hicks, Brian J Yoder, James Pettay, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 8, 2024
Neoadjuvant Reirradiation for Radiation Therapy-Associated Angiosarcoma of the Breast
Wafa Asha, Zahraa Al-Hilli, Risal Djohan, et al.
Breast (Edinburgh, Scotland)
|
May 24, 2006
A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institution
Joseph P Crowe, Rebecca J Patrick, Lisa A Rybicki, et al.
American Journal of Clinical Oncology
|
September 23, 2009
S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach
Charles D Blanke, Kari Chansky, Kathy L Christman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 18, 2012
Delay to formalin fixation 'cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry
Bryce P Portier, Zhen Wang, Erinn Downs-Kelly, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 103) with videos related to
Sort By:
Page
of 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2014
Trastuzumab emtansine in human epidermal growth factor receptor 2-positive metastatic breast cancer: an integrated safety analysis
Véronique Diéras, Nadia Harbeck, G Thomas Budd, et al.
Breast Cancer Research and Treatment
|
April 28, 2004
A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer
Gary H Lyman, Stephanie J Green, Peter M Ravdin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 8, 2012
Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy
Rahul D Tendulkar, Sana Rehman, Monica E Shukla, et al.
Cancer
|
February 14, 2017
Impact of an alternative chromosome 17 probe and the 2013 American Society of Clinical Oncology and College of American Pathologists guidelines on fluorescence in situ hybridization for the determination of HER2 gene amplification in breast cancer
Alana R Donaldson, Shashirekha Shetty, Zhen Wang, et al.
Clinical Breast Cancer
|
November 6, 2021
Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors
Hanjie Mo, Catherine E Renna, Halle C F Moore, et al.
Human Pathology
|
May 14, 2005
The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study
David G Hicks, Brian J Yoder, James Pettay, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 8, 2024
Neoadjuvant Reirradiation for Radiation Therapy-Associated Angiosarcoma of the Breast
Wafa Asha, Zahraa Al-Hilli, Risal Djohan, et al.
Breast (Edinburgh, Scotland)
|
May 24, 2006
A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institution
Joseph P Crowe, Rebecca J Patrick, Lisa A Rybicki, et al.
American Journal of Clinical Oncology
|
September 23, 2009
S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach
Charles D Blanke, Kari Chansky, Kathy L Christman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 18, 2012
Delay to formalin fixation 'cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry
Bryce P Portier, Zhen Wang, Erinn Downs-Kelly, et al.
Page
of 11